Pregene's Unattributed VC Round

Pregene raised a round of funding on May 16, 2018. Investors include CASH Capital Investment Management.

Pregene (普瑞金) is a biopharmaceutical company that focuses on the development of the CAR T-cell therapy.…

Articles about Pregene's Unattributed VC Round: